The Croatian market for hormones in dosage, excluding contraceptives and antibiotics, witnessed a fluctuating trend over the past decade. Starting at 94.506 million USD in 2013, the market experienced a dip towards 2016, followed by a rebound in 2017 and 2018. By 2023, the market value stood at 92.541 million USD, indicating minor fluctuations compared to previous years.
Year-on-year analysis reveals a 0.88% contraction in 2023, while the five-year CAGR reflects a negative trend of -1.69%. This suggests a mild decline over the recent years after a peak in 2021.
Future trends to watch for in this market include the potential impact of innovations in hormone therapies and regulatory changes. Additionally, shifts in healthcare policies and economic conditions might influence market dynamics, suggesting a need for close monitoring of both technological advancements and policy landscapes.
